APA (7th ed.) Citation

Claustre, G., Boulanger, C., Maloisel, F., Etienne-Selloum, N., Fornecker, L., Durot, E., . . . Graff, V. (2023). Comparative analysis of rituximab or obinutuzumab combined with CHOP in first-line treatment of follicular lymphoma. Journal of Cancer Research and Clinical Oncology, 149(5), 1883-1893. https://doi.org/10.1007/s00432-022-04155-2

Chicago Style (17th ed.) Citation

Claustre, Gwladys, Coralie Boulanger, Frédéric Maloisel, Nelly Etienne-Selloum, Luc-Matthieu Fornecker, Eric Durot, Florian Slimano, and Véronique Graff. "Comparative Analysis of Rituximab or Obinutuzumab Combined with CHOP in First-line Treatment of Follicular Lymphoma." Journal of Cancer Research and Clinical Oncology 149, no. 5 (2023): 1883-1893. https://doi.org/10.1007/s00432-022-04155-2.

MLA (9th ed.) Citation

Claustre, Gwladys, et al. "Comparative Analysis of Rituximab or Obinutuzumab Combined with CHOP in First-line Treatment of Follicular Lymphoma." Journal of Cancer Research and Clinical Oncology, vol. 149, no. 5, 2023, pp. 1883-1893, https://doi.org/10.1007/s00432-022-04155-2.